| Eric Da Silva, DO | |
|
1 Genesys Pkwy Ste 4595, Grand Blanc, MI 48439-8065 | |
| (810) 498-6350 | |
| Not Available |
| Full Name | Eric Da Silva |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 1 Genesys Pkwy Ste 4595, Grand Blanc, Michigan |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144672189 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 5101022726 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Eric Da Silva, DO 1 Genesys Pkwy Ste 4595, Grand Blanc, MI 48439-8065 Ph: (810) 498-6350 | Eric Da Silva, DO 1 Genesys Pkwy Ste 4595, Grand Blanc, MI 48439-8065 Ph: (810) 498-6350 |
News Archive
As health care reform expands the use of "report cards" to grade health care providers, greater attention to reporting methods may be needed to assure the quality of such efforts, according to a new RAND Corporation study.
"Two years after the launch of a global effort to mobilize countries in the use of scientific approaches to improve nutrition, the movement seems to be gaining momentum," IRIN reports, noting, "More than 30 countries have signed up with the Scaling Up Nutrition Movement, better known by its acronym SUN."
A somewhat mysterious soft tissue found in the fetus during early development in the womb plays a pivotal role in the formation of mature beta cells the sole source of the body's insulin. This discovery, made by scientists at University of California, San Francisco (UCSF) and Texas A&M University, may lead to new ways of addressing Type 1 and Type 2 diabetes.
Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including muscle, bone, fat, red blood cells and the vasculature, today announced the initiation of a Phase 2 clinical trial with ACE-031 in patients with Duchenne Muscular Dystrophy (DMD), a fatal neuromuscular disease. ACE-031 is an investigational protein therapeutic that builds muscle and increases strength by inhibiting signaling of a cell surface receptor called the activin receptor type IIB (ActRIIB).
› Verified 6 days ago
Dr. Antony James Daros, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8275 Holly Rd, Ste 1, Grand Blanc, MI 48439 Phone: 810-603-0990 Fax: 810-603-1678 | |
Edna Bick, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 8447 Holly Rd, Ste D, Grand Blanc, MI 48439 Phone: 810-695-9451 Fax: 810-695-9469 | |
Michael Briggs, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Genesys Pkwy, Grand Blanc, MI 48439 Phone: 810-606-6137 | |
Dr. Karthiyayini Satkunananthan, M.D Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1 Genesys Pkwy, Grand Blanc, MI 48439 Phone: 810-606-5000 | |
Dr. Spencer Ryan Copeland, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 1 Genesys Pkwy, Grand Blanc, MI 48439 Phone: 810-606-5000 | |
Dr. Guru Kandasamy, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1 Genesys Pkwy, Grand Blanc, MI 48439 Phone: 810-606-5000 | |
Adriana Collazo Ortiz, MD Family Medicine Medicare: Medicare Enrolled Practice Location: Ascension Genesys, Gme Dept, One Genesys Pkwy, Grand Blanc, MI 48439 Phone: 800-233-2863 |